Rankings
▼
Calendar
KURA FY 2011 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena
KURA
Kura Oncology, Inc.
$792M
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$23,440
Operating Income
-$20,509
Net Income
-$22,395
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$19,244
Free Cash Flow
-$19,244
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$6,720
Total Liabilities
$74,751
Stockholders' Equity
-$68,031
Cash & Equivalents
$4,220
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$23,440
-$20,509
-14.3%
Operating Income
-$20,509
-$41,018
+50.0%
Net Income
-$22,395
-$22,395
+0.0%
← FY 2010
All Quarters
FY 2012 →